Targeting Pre-Diabetes and Insulin Resistance Pre-diabetes is a condition where blood sugar levels are higher than normal but not high enough yet for a diagnosis of type 2 diabetes
Ann Gastroenterol
doi:10.1016/s1808-8694(15)30967-8
So you compound it by making it into a slurry or into a liquid
The forces involved in squirting a liquid directly onto the powder or, even worse, shaking the vial vigorously can be enough to shear those delicate peptide bonds apart

Pre-existing conditions that increase risk Researchers with the following conditions should discuss retatrutide heart rate effects with their physician before starting a protocol: History of atrial fibrillation or other arrhythmias - the increased contractile force and rate from glucagon receptor activation could potentially trigger or worsen existing rhythm disorders Heart failure - while increased contractility might seem beneficial, the increased cardiac workload from higher heart rate can worsen heart failure in some cases Hyperthyroidism - thyroid hormone excess already increases heart rate, and adding retatrutide could produce additive effects Anxiety disorders or panic disorder - heightened awareness of cardiac sensations can trigger anxiety episodes in susceptible individuals Use of stimulant medications - amphetamines, methylphenidate, and similar drugs increase heart rate through sympathetic activation, and combining them with retatrutide glucagon receptor effects could produce larger-than-expected increases For most healthy adults without these conditions, a gradual dose escalation starting at lower doses allows the cardiovascular system to adapt and minimizes the risk of abrupt, uncomfortable heart rate changes
